Skip to main content

Methods for Measuring and Estimating Costs

  • Chapter
  • First Online:
Mental Health Economics

Abstract

This chapter focuses on costing methods usually applied in cost analysis and health-related economic evaluations. The quality of an economic evaluation depends on the quality and precision of data collection and on transparency and comprehensivenness of costing resources. Costs, from an economic perspective, are related to opportunity costs; this economic conceptualization is different from a financial perspective. Costs are classified as direct, indirect, intangible, and total costs. In this chapter I focus exclusively on the measurement of direct costs. Costing involves multiple steps: choosing the perspective of the study; identifying the component of costs, collecting data on costs and services use, estimating the unit cost for each resource, and estimating costs. Although the majority of economic evaluations includes only direct costs, indirect costs correspond to the major parcel of diseases costs. Mental disorders, for instance, cause innumerable negative externalities and indirect costs, and the benefits of psychiatric and psychosocial interventions go beyond clinical improvement, leading to systematic recommendations for measuring costs in a comprehensive way, such as using societal perspective. There is a debate among health economists regarding the inclusion of indirect costs in the economic evaluation, though, thieir exclusion in assessing cost-effectivenness, for instance, might understimate the economic impact of psychiatric intervention. Costing methods for indirect costs are discussed in another chapter in this book.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Reference

  1. Mogyorosy Z, Smith P. The main methodological issues in costing health care services. Centre for Health Economics, University of York; 2005. 12 Feb 2016.

    Google Scholar 

  2. Barnett PG. Review of methods to determine VA health care costs. Med Care. 1999;37(4 Suppl Va):AS9–17.

    CAS  PubMed  Google Scholar 

  3. Luce BR, Elixhauser A. Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess Health Care. 1990;6(1):57–75.

    Article  CAS  PubMed  Google Scholar 

  4. Garrison Jr LP, Mansley E, Abbott T, Bresnahan B, Hay J, Smeedin J. Good research practices for measuring drug costs in cost-effectiveness analyses: a societal Perpective the ISPOR drug costs task force report – part II. Value Health. 2010;13(1):8–13.

    Article  PubMed  Google Scholar 

  5. Drummond M, McGuire A. Economic evaluation in health care: merging theroy with practice. 2nd ed. New York: Oxford University Press; 2004.

    Google Scholar 

  6. Shearer J, McCrone P, Romeo R. Economic evaluation of mental health interventions: a guide to costing approaches. PharmacoEconomics. 2016;34(7):651–64.

    Article  Google Scholar 

  7. Drummond MF, Sculpher MJ, Torrance GW, O` Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2007.

    Google Scholar 

  8. Smith MW, Barnett PG. Direct measurement of health care costs. Med Care Res Rev. 2003;60(3 Suppl):74S–91S.

    Article  PubMed  Google Scholar 

  9. Beecham J. Collecting and estimating costs. In: Knapp M, editor. The economic evaluation of mental health care. 1st ed. Aldershot: Arena; 1995. p. 61–82.

    Google Scholar 

  10. Beecham J, Knapp M. Costing psychiatric interventions. In: Thornicroft G, editor. Measuring mental health needs. London: Gaskell; 2001. p. 200–24.

    Google Scholar 

  11. Byford S, McDaid D, Sefton T. Because it’s worth it: a practical guide to conducting economic evaluations in the social welfare field. 2003. London, York Publishing Services Ltd.

    Google Scholar 

  12. Brouwer W, Rutten F, Koopmanschap M. Costing in economic evaluation. In: Drummond M, McGuire A, editors. Economic evaluation in health care: merging theory with practice. 2nd ed. Oxford: Oxford University Press; 2004. p. 68–93.

    Google Scholar 

  13. Slothuus U. An evaluation of selected literature on the measurement of costs in health economic evaluations. Odense: Syddansk Universitets Trykkeri. Health Economics Papers, 3. 2000. http://www.sdu.dk/-/media/files/om_sdu/centre/cohere/working+papers/20005.pdf

  14. Institute for Quality and Efficiency in Health Care (IQWiG). Working paper: cost estimation. Cologne; 2009.

    Google Scholar 

  15. Jacobs P, Fassbender K. The measurement of indirect costs in the health economics evaluation literature. A review. Int J Technol Assess Health Care. 1998;14(4):799–808.

    Article  CAS  PubMed  Google Scholar 

  16. Barnett PG. An improved set of standards for finding cost for cost-effectiveness analysis. Med Care. 2009;47(7 Suppl 1):S82–8.

    Article  PubMed  Google Scholar 

  17. Heerey A, McGowan B, Ryan M, Barry M. Microcosting versus DRGs in the provision of cost estimates for use in pharmacoeconomic evaluation. Expert Rev Pharmacoecon Outcomes Res. 2002;2(1):29–33.

    Article  Google Scholar 

  18. Oostenbrink JB, oopmanschap MA, Rutten FF. Standardisation of costs: the Dutch manual for costing in economic evaluations. PharmacoEconomics. 2002;20(7):443–54.

    Article  Google Scholar 

  19. Drummond M, Sculpher MJ. Common methodological flaws in economic evaluations. Med Care. 2005;43(suppl7):II5–II14.

    Google Scholar 

  20. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. Value Health. 2013;16(2):e1–5.

    Article  PubMed  Google Scholar 

  21. Adam T, Evans D. Cost-effectiveness analysis: can we reduce variability in costing methods? Int J Technol Assess Health Care. 2003;19(2):407–20.

    Article  PubMed  Google Scholar 

  22. Edwards RT, Charles JM, Lloyd-Williams H. Public health economics: a systematic review of guidance for the economic evaluation of public health interventions and discussion of key methodological issues. BMC Public Health. 2013;13:1001.

    Article  PubMed  PubMed Central  Google Scholar 

  23. McCrone P. Mental health economics: current methodological issues. Epidemiol Psychiatr Sci. 2011;20(3):239–43.

    Article  CAS  PubMed  Google Scholar 

  24. McCrone P, Weich S. Mental health care costs: paucity of measurement. Soc Psychiatry Psychiatr Epidemiol. 1996;31(2):70–7.

    Article  CAS  PubMed  Google Scholar 

  25. Knapp M. The economic evaluation of mental health care. 1st ed. Ashgate Publishing Limited; 1995.

    Google Scholar 

  26. Jönsson B. Ten arguments for a societal perspective in the economic evaluation of medical innovations. Eur J Health Econ. 2009;10:357–9.

    Article  Google Scholar 

  27. Neumann PJ. Costing and perspective in published cost-effectiveness analysis. Med Care. 2009;47(7 Suppl 1):S28–32.

    Article  PubMed  Google Scholar 

  28. Hu TW. Perspectives: an international review of the national cost estimates of mental illness, 1990–2003. J Ment Health Policy Econ. 2006;9(1):3–13.

    PubMed  Google Scholar 

  29. Unutzer J, Katon WJ, Russo J, Simon G, Von KM, Lin E, et al. Willingness to pay for depression treatment in primary care. Psychiatr Serv. 2003;54(3):340–5.

    Article  PubMed  Google Scholar 

  30. Xu K, Evans DB, Kawabata K, Zeramdini R, Murray C. Household catastrophic health expenditure: a multicountry analysis. Lancet. 2003;362:111–7.

    Article  PubMed  Google Scholar 

  31. Tai B, Bae Y, Le Q. A systematic review of health economic evaluation studies using the patient’s perspective. Value Health. 2016;19(6):903–8.

    Article  PubMed  Google Scholar 

  32. Koopmanschap MA, Rutten FF, van Ineveld BM, van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ. 1995;14(2):171–89.

    Article  CAS  PubMed  Google Scholar 

  33. Knapp M, Beecham J. Reduced list costings: examination of an informed short cut in mental health research. Health Econ. 1993;2(4):313–22.

    Article  CAS  PubMed  Google Scholar 

  34. Knapp M, Razzouk D. Costs of schizophrenia. Psychatry. 2008;7(11):491–4.

    Article  Google Scholar 

  35. Mangalore R, Knapp M. Cost of schizophrenia in England. J Ment Health Policy Econ. 2007;10(1):23–41.

    PubMed  Google Scholar 

  36. Cidav Z, Marcus SC, Mandell DS. Implications of childhood autism for parental employment and earnings. Pediatrics. 2012;129(4):617–23.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Barrett B, Byford S, Sharac J, udry K, Leadbitter K, emple K, et al. Service and wider societal costs of very young children with autism in the UK. J Autism Dev Disord. 2012;42:797–804.

    Article  PubMed  Google Scholar 

  38. Knapp M. Hidden costs of mental illness. Br J Psychiatry. 2003;183:477–8.

    Article  PubMed  Google Scholar 

  39. Miller T, Levy D, Cohen M, Cox KL. Costs of alcohol and drug-involved crime. Prev Sci. 2006;7(4):333–42.

    Article  PubMed  Google Scholar 

  40. Chisholm D, Evans D. Economic evaluation in health: saving money or improving care? J Med Econ. 2007;10:325–37.

    Article  Google Scholar 

  41. Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, et al. Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1). Arch Gen Psychiatry. 2006;63(10):1079–87.

    Article  CAS  PubMed  Google Scholar 

  42. Trautmann S, Rehm J, Wittchen HU. The economic costs of mental disorders: do our societies react appropriately to the burden of mental disorders? EMBO Rep. 2016;17(9):1245–9.

    Article  CAS  Google Scholar 

  43. McDaid D, Knapp M, Medeiros H. MHEEN group. Employment and mental health: assessing the economic impact and the case for intervention. London: London School of Economics & Political Science; 2008.

    Google Scholar 

  44. Weatherly H, Drummond M, Claxton K, Cookson R, Ferguson B, Godfrey C, et al. Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations. Health Policy. 2009;93(2–3):85–92.

    Article  PubMed  Google Scholar 

  45. Hallam A, Trieman N. The cost effectiveness of specialised facilities for service users with persistent challenging behaviours. Health Soc Care Community. 2001;9(6):429–35.

    Article  CAS  PubMed  Google Scholar 

  46. Slothuus U. An evaluation of selected literature on the measurement of costs in health economic evaluations. Odense: Syddansk Universitets Trykkeri. (Health economics papers, 3); 2000.

    Google Scholar 

  47. Gray A, Clarke P, Wolstenholme J, Worsworth S. Applied methods of cost-effectiveness analysis in health care. 1st ed. Oxford: Oxford University Press; 2011.

    Google Scholar 

  48. Byford S, Leese M, Knapp M, Seivewright H, Cameron S, Jones V, et al. Comparison of alternative methods of collection of service use data for the economic evaluation of health care interventions. Health Econ. 2007;16(5):531–6.

    Article  PubMed  Google Scholar 

  49. Chisholm D, Knapp MKH, Amaddeo F, Gaite L, Winjgaarden B. Client socio-demographic service receipt inventory European version: development of one intrument for international research. Br J Psychiatry. 2000;177(39):s28–33.

    Article  Google Scholar 

  50. Riewpaiboon A, Malaroje S, Kongsawatt S. Effect of costing methods on unit cost of hospital medical services. Tropical Med Int Health. 2007;12(4):554–63.

    Article  Google Scholar 

  51. Oostenbrink JB, Buijs-Van der Woude T, van Agthoven M, Koopmanschap MA, Rutten FF. Unit costs of inpatient hospital days. PharmacoEconomics. 2003;21(4):263–71.

    Article  PubMed  Google Scholar 

  52. McFarkand B, Smith J, Bigelow D, Mofidi A. Unit of costs of community mental health services. Admin Pol Ment Health. 1995;23(1):27–42.

    Article  Google Scholar 

  53. Curtis L, Burn A. Unit of costs of health & social care 2015. Personal Social Services Research Unit; 2015.

    Google Scholar 

  54. Mullins C, Seal B, Seoane-Vasquez E, Sankaranarayanan J, Asche C, Jayadevappa R, et al. Good research practices for measuring drug costs in cost-effectiveness analyses: medicare, medicaid and other US government payers perspectives: the ISPOR drug cost task force report—part IV. Value Health. 2010;13(1):18–24.

    Article  PubMed  Google Scholar 

  55. Mansley E, Carroll N, Chen K, Shah N. Good research practices for measuring drug costs in cost-effectiveness analyses: a managed care perspeective: the ISPOR drug cost task force report-part III. Value Health. 2010;13(1):14–7.

    Article  PubMed  Google Scholar 

  56. South American Institute of Government in Health, Giovanella L, Feo O, Faria M, Tobar K. Health systems in South America: challenges to universality, integrality and equity. Rio de Janeiro: ISAGS; 2012.

    Google Scholar 

  57. Razzouk D, Kayo M, Sousa A, Gregorio G, Cogo-Moreira H, Cardoso AA, et al. The impact of antipsychotic polytherapy costs in the public health care in Sao Paulo, Brazil. PLoS One. 2015;10(4):e0124791.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Denise Razzouk .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Razzouk, D. (2017). Methods for Measuring and Estimating Costs. In: Razzouk, D. (eds) Mental Health Economics. Springer, Cham. https://doi.org/10.1007/978-3-319-55266-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-55266-8_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-55265-1

  • Online ISBN: 978-3-319-55266-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics